Skip to main content
HR 3258 117th Congress House

TACT Act of 2021

Official title: To amend title XXVII of the Public Health Service Act to improve patient access to anti-cancer oral medications, and for other purposes.

Introduced: March 29, 2022 Introduced by: Sewell, Terri A. Democratic · Alabama See on congress.gov
Health Congressional oversightGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessPrescription drugs
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 17, 2021
Referred to the Subcommittee on Health.
May 14, 2021
Referred to the House Committee on Energy and Commerce.
May 14, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 17, 2021

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Timely Access to Cancer Treatment Act of 2021 or the TACT Act of 2021

This bill requires insurance plans to authorize, and pharmacies contracted with the plans to dispense, anti-cancer oral medications within certain time frames.

Specifically, within 24 hours after receiving a prescription, a pharmacy must inform the health care provider and plan enrollee whether it will dispense the medication. If the pharmacy will dispense the medication, it must do so within 72 hours after receiving the prescription. If the pharmacy is unable to dispense the medication, it must notify in writing the prescribing health care provider, the insurance plan, and the plan enrollee. A plan that requires prior authorization for anti-cancer oral medication must make that determination within 72 hours after receiving the request for authorization.

Further, if a pharmacy provides notification that it is unable to dispense the medication, the health insurance plan must allow the enrollee to select a different pharmacy to dispense the medication, even if that pharmacy does not have a contract with the plan. In such a case, the plan may not require additional prior authorization or cost sharing.

The Government Accountability Office must evaluate and report on the implementation of these requirements.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3258: TACT Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-3258/
MLA
"H.R. 3258: TACT Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-3258/.
Bluebook (legal)
H.R. 3258, 117th Cong. (2026), https://openamerica.io/bill/117-HR-3258/.
Markdown link
[H.R. 3258: TACT Act of 2021](https://openamerica.io/bill/117-HR-3258/)
Report a problem